Companies in the genetics sector developing innovative solutions and technologies.
Explore 328 recently funded genetics companies with verified founder contact information and fundraising data.
Maze Therapeutics is a biotechnology company that develops precision medicines for renal, cardiovascular, and metabolic diseases.
Simmunome is an artificial intelligence-based contract research organization.
Eugene apps make it easy to order genetic tests, connect with counselors, get referrals, & see all reports in one place.
ReviR Therapeutics is a genomics-based platform that develops novel medicines targeting human RNAs.
Center for Aquaculture Technologies is a research and development company using all modern genetic improvement technologies.
Canal Biosciences is a precision medicine company that offers DNA library preparation technologies for advanced genomics.
InVivo Biosystems specializes in genome editing and preclinical research for neurological, metabolic, and rare monogenic diseases.
Minicircle develops a human genetic enhancement platform to facilitate life extension capabilities.
Function Oncology is a precision medicine company advancing a CRISPR-powered personalized functional genomics platform.
Tacit Therapeutics created RNA-targeting treatments for devastating diseases.
QurAlis is a biotechnology company that creates precision medicine solutions to cure ALS and FTD.
Girihlet is a provider of rapid and accurate deep sequencing services with a unique focus on developing novel technologies.
DNALite Therapeutics is an early-stage preclinical biotechnology company.
Solid Biosciences is a life science company that conducts research for the treatment of Duchenne muscular dystrophy.
Swan Genomics is focused on commercialising an innovative new approach to DNA sequencing to deliver more accessible genomics data.
Sionna Therapeutics is developing novel small molecule therapies to treat cystic fibrosis (CF).
Enabling tomorrow's therapies manufacturing for today's patients, with sound
Orchard Therapeutics is a biotechnology company dedicated to assisting patients through innovative gene therapies.
Alithea Genomics develops molecular biology tools and sequencing-based solutions for large-scale gene expression analysis.
Phase Genomics develops a biotechnology platform for new discoveries in agriculture, human health, and industrial biology industries.
Jaguar Gene Therapy is accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases.
Fortuna is a biotechnology company that provides forecasting and screening technology solutions for non-invasive embryo trait assessment.
Flomics mines the nucleic acids in your fluids to create affordable, non-invasive and accurate diagnostics
3X Genetics develops medical screening solutions to identify genetic disorders.
CirculoGene specializes in the fields of cfDNA, liquid biopsy, tumor monitoring, laboratory testing, and molecular diagnostics.
The genetics sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.
Genetics companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.
The genetics sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.
Here is how funding is distributed among the 328 genetics companies tracked in the VCBacked database.
Companies in the genetics sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.
Perfect for: B2B sales teams targeting genetics companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.
Get Started - Access Contact InformationJoin thousands of sales teams, investors, and service providers using VCBacked